Brief: Avenue Therapeutics Q2 EPS USD -0.52
10/08/2023 21:16
Aug 10 (Reuters) - Avenue Therapeutics Q2 EPS USD -0.52. * Q2 operating income USD -3.923 million * Q2 net income USD -4.016 million
Recent news on Avenue Therapeutics
See all newsBrief: Axsome Therapeutics Acquires AZD7325, A Selective GABA-A Modulator For Treatment Of Epilepsy
Avenue Therapeutics Inc expected to post a loss of 57 cents a share - Earnings Preview
Brief: Avenue Therapeutics Annji Intends To Terminate License Agreement With Co
Brief: Avenue Therapeutics Receives Delist Letter From Nasdaq Under Nasdaq Listing Rule 5550(B)(1)
Avenue Therapeutics Inc reports results for the quarter ended September 30 - Earnings Summary